Cargando…
Non-toxic antimicrobials that evade drug resistance
Drugs that act more promiscuously provide fewer routes for the emergence of resistant mutants. But this benefit often comes at the cost of serious off-target and dose-limiting toxicities. The classic example is the antifungal amphotericin B (AmB), which has evaded resistance for more than half a cen...
Autores principales: | Davis, Stephen A., Vincent, Benjamin M., Endo, Matthew M., Whitesell, Luke, Marchillo, Karen, Andes, David R., Lindquist, Susan, Burke, Martin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472574/ https://www.ncbi.nlm.nih.gov/pubmed/26030729 http://dx.doi.org/10.1038/nchembio.1821 |
Ejemplares similares
-
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
por: Vincent, Benjamin Matteson, et al.
Publicado: (2013) -
In vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Staphylococcus aureus (SA) in the Murine Thigh Infection Model
por: Lepak, Alexander J, et al.
Publicado: (2017) -
Evading resistance to gene drives
por: Gomulkiewicz, Richard, et al.
Publicado: (2021) -
Chaperones as thermodynamic sensors of drug–target interactions reveal kinase inhibitor specificities in living cells
por: Taipale, Mikko, et al.
Publicado: (2013) -
Identification of antibiotic pairs that evade concurrent resistance via a retrospective analysis of antimicrobial susceptibility test results
por: Beckley, Andrew M, et al.
Publicado: (2021)